Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β

Mee Ohk Kim, Hyeon Sook Suh, Celia F. Brosnan, Sunhee C. Lee

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

In the CNS, astrocytes are significant sources of RANTES/CCL5 (regulated upon activation, normal T cell expressed and secreted), a CC-chemokine with important biological function. Astrocyte RANTES/CCL5 has been shown to be induced by interleukin-1 (IL-1), with interferon-γ (IFNγ) as a primer, but whether type I interferons play any role in the expression of RANTES/CCL5 is not known. In this report, we studied the detailed mechanism of RANTES/CCL5 induction in primary human astrocytes activated with IL-1 and IFNβ. Ribonuclease protection assay and ELISA showed that IFNβ, although not effective alone, increased IL-1-induced RANTES/CCL5 expression, but did not antagonize IFNγ. IL-1 or IL-1/IFNβ-induced RANTES/CCL5 expression was inhibited by the super-repressor IκBα or inhibitors of p38 or c-Jun N-terminal kinase (JNK) MAPKs (mitogen-activated protein kinases), but not by extracellular signal regulated kinases (ERK) inhibitors. IFNβ enhanced IL-1-induced phosphorylation of p38 MAPK, but was not effective alone. Transfection with mutated RANTES/CCL5 promoter-reporter constructs revealed that κB, interferon-stimulated response element (ISRE) and CAATT-enhancer binding protein-β (C/EBPβ) sites all contributed to IL-1/IFNβ-induced RANTES/CCL5 transcription. IFNβ synergized with IL-1 to induce nuclear accumulation of C/EBPβ protein. They also synergized to form nuclear ISRE complexes with Stat1, Stat2 and interferon regulatory factor-1 (IRF-1) proteins. Together, our results demonstrate that IFNβ plays a positive regulatory role in the expression of RANTES/CCL5 in human astrocytes through several distinct mechanisms.

Original languageEnglish (US)
Pages (from-to)297-308
Number of pages12
JournalJournal of Neurochemistry
Volume90
Issue number2
DOIs
StatePublished - Jul 2004

Fingerprint

Chemokine CCL5
Interleukin-1
Astrocytes
Interferons
Response Elements
Carrier Proteins
Interferon Regulatory Factor-1
CC Chemokines
Interferon Type I
Phosphorylation
T-cells
JNK Mitogen-Activated Protein Kinases
Extracellular Signal-Regulated MAP Kinases
p38 Mitogen-Activated Protein Kinases
Transcription
Ribonucleases
Mitogen-Activated Protein Kinases
Transfection
Assays
Proteins

Keywords

  • Brain
  • Chemokine
  • Human
  • Promoter
  • Transcription

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β. / Kim, Mee Ohk; Suh, Hyeon Sook; Brosnan, Celia F.; Lee, Sunhee C.

In: Journal of Neurochemistry, Vol. 90, No. 2, 07.2004, p. 297-308.

Research output: Contribution to journalArticle

Kim, Mee Ohk ; Suh, Hyeon Sook ; Brosnan, Celia F. ; Lee, Sunhee C. / Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β. In: Journal of Neurochemistry. 2004 ; Vol. 90, No. 2. pp. 297-308.
@article{6cc7a26471564a43afbbd7bb113547d1,
title = "Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β",
abstract = "In the CNS, astrocytes are significant sources of RANTES/CCL5 (regulated upon activation, normal T cell expressed and secreted), a CC-chemokine with important biological function. Astrocyte RANTES/CCL5 has been shown to be induced by interleukin-1 (IL-1), with interferon-γ (IFNγ) as a primer, but whether type I interferons play any role in the expression of RANTES/CCL5 is not known. In this report, we studied the detailed mechanism of RANTES/CCL5 induction in primary human astrocytes activated with IL-1 and IFNβ. Ribonuclease protection assay and ELISA showed that IFNβ, although not effective alone, increased IL-1-induced RANTES/CCL5 expression, but did not antagonize IFNγ. IL-1 or IL-1/IFNβ-induced RANTES/CCL5 expression was inhibited by the super-repressor IκBα or inhibitors of p38 or c-Jun N-terminal kinase (JNK) MAPKs (mitogen-activated protein kinases), but not by extracellular signal regulated kinases (ERK) inhibitors. IFNβ enhanced IL-1-induced phosphorylation of p38 MAPK, but was not effective alone. Transfection with mutated RANTES/CCL5 promoter-reporter constructs revealed that κB, interferon-stimulated response element (ISRE) and CAATT-enhancer binding protein-β (C/EBPβ) sites all contributed to IL-1/IFNβ-induced RANTES/CCL5 transcription. IFNβ synergized with IL-1 to induce nuclear accumulation of C/EBPβ protein. They also synergized to form nuclear ISRE complexes with Stat1, Stat2 and interferon regulatory factor-1 (IRF-1) proteins. Together, our results demonstrate that IFNβ plays a positive regulatory role in the expression of RANTES/CCL5 in human astrocytes through several distinct mechanisms.",
keywords = "Brain, Chemokine, Human, Promoter, Transcription",
author = "Kim, {Mee Ohk} and Suh, {Hyeon Sook} and Brosnan, {Celia F.} and Lee, {Sunhee C.}",
year = "2004",
month = "7",
doi = "10.1111/j.1471-4159.2004.02487.x",
language = "English (US)",
volume = "90",
pages = "297--308",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-β

AU - Kim, Mee Ohk

AU - Suh, Hyeon Sook

AU - Brosnan, Celia F.

AU - Lee, Sunhee C.

PY - 2004/7

Y1 - 2004/7

N2 - In the CNS, astrocytes are significant sources of RANTES/CCL5 (regulated upon activation, normal T cell expressed and secreted), a CC-chemokine with important biological function. Astrocyte RANTES/CCL5 has been shown to be induced by interleukin-1 (IL-1), with interferon-γ (IFNγ) as a primer, but whether type I interferons play any role in the expression of RANTES/CCL5 is not known. In this report, we studied the detailed mechanism of RANTES/CCL5 induction in primary human astrocytes activated with IL-1 and IFNβ. Ribonuclease protection assay and ELISA showed that IFNβ, although not effective alone, increased IL-1-induced RANTES/CCL5 expression, but did not antagonize IFNγ. IL-1 or IL-1/IFNβ-induced RANTES/CCL5 expression was inhibited by the super-repressor IκBα or inhibitors of p38 or c-Jun N-terminal kinase (JNK) MAPKs (mitogen-activated protein kinases), but not by extracellular signal regulated kinases (ERK) inhibitors. IFNβ enhanced IL-1-induced phosphorylation of p38 MAPK, but was not effective alone. Transfection with mutated RANTES/CCL5 promoter-reporter constructs revealed that κB, interferon-stimulated response element (ISRE) and CAATT-enhancer binding protein-β (C/EBPβ) sites all contributed to IL-1/IFNβ-induced RANTES/CCL5 transcription. IFNβ synergized with IL-1 to induce nuclear accumulation of C/EBPβ protein. They also synergized to form nuclear ISRE complexes with Stat1, Stat2 and interferon regulatory factor-1 (IRF-1) proteins. Together, our results demonstrate that IFNβ plays a positive regulatory role in the expression of RANTES/CCL5 in human astrocytes through several distinct mechanisms.

AB - In the CNS, astrocytes are significant sources of RANTES/CCL5 (regulated upon activation, normal T cell expressed and secreted), a CC-chemokine with important biological function. Astrocyte RANTES/CCL5 has been shown to be induced by interleukin-1 (IL-1), with interferon-γ (IFNγ) as a primer, but whether type I interferons play any role in the expression of RANTES/CCL5 is not known. In this report, we studied the detailed mechanism of RANTES/CCL5 induction in primary human astrocytes activated with IL-1 and IFNβ. Ribonuclease protection assay and ELISA showed that IFNβ, although not effective alone, increased IL-1-induced RANTES/CCL5 expression, but did not antagonize IFNγ. IL-1 or IL-1/IFNβ-induced RANTES/CCL5 expression was inhibited by the super-repressor IκBα or inhibitors of p38 or c-Jun N-terminal kinase (JNK) MAPKs (mitogen-activated protein kinases), but not by extracellular signal regulated kinases (ERK) inhibitors. IFNβ enhanced IL-1-induced phosphorylation of p38 MAPK, but was not effective alone. Transfection with mutated RANTES/CCL5 promoter-reporter constructs revealed that κB, interferon-stimulated response element (ISRE) and CAATT-enhancer binding protein-β (C/EBPβ) sites all contributed to IL-1/IFNβ-induced RANTES/CCL5 transcription. IFNβ synergized with IL-1 to induce nuclear accumulation of C/EBPβ protein. They also synergized to form nuclear ISRE complexes with Stat1, Stat2 and interferon regulatory factor-1 (IRF-1) proteins. Together, our results demonstrate that IFNβ plays a positive regulatory role in the expression of RANTES/CCL5 in human astrocytes through several distinct mechanisms.

KW - Brain

KW - Chemokine

KW - Human

KW - Promoter

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=3142777716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142777716&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2004.02487.x

DO - 10.1111/j.1471-4159.2004.02487.x

M3 - Article

C2 - 15228586

AN - SCOPUS:3142777716

VL - 90

SP - 297

EP - 308

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -